PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 118 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2021. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $9,113,000 | -23.6% | 1,300,000 | 0.0% | 2.12% | -15.2% |
| Q2 2021 | $11,934,000 | -5.6% | 1,300,000 | 0.0% | 2.50% | -4.2% |
| Q1 2021 | $12,636,000 | -5.3% | 1,300,000 | 0.0% | 2.61% | +20.6% |
| Q4 2020 | $13,338,000 | +19.9% | 1,300,000 | +18.0% | 2.17% | +116.6% |
| Q3 2020 | $11,120,000 | +1052.3% | 1,102,073 | +1091.4% | 1.00% | +1198.7% |
| Q2 2020 | $965,000 | -97.2% | 92,502 | -89.7% | 0.08% | -97.8% |
| Q1 2019 | $34,911,000 | +24.3% | 900,000 | -34.8% | 3.46% | -2.6% |
| Q4 2018 | $28,077,000 | -99.9% | 1,379,700 | +175.9% | 3.55% | -29.8% |
| Q1 2018 | $34,025,000,000 | – | 500,000 | – | 5.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
| Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
| BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
| WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
| TOBAM | 318,384 | $23,994,000 | 0.94% |
| Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
| Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
| CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |